Author

D. A. Carrera

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:CITE-seq· 1 Research Focus:clustering· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

H. Okada· 2 shared A. A. Diaz· 1 shared A. Celli· 1 shared A. Naik· 1 shared A. P. Wiita· 1 shared A. Shai· 1 shared A. W. Li· 1 shared A. Wang· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

H. Okada

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma

T. Nejo, L. Wang, K. K. Leung, A. Wang, S. Lakshmanachetty, M. Gallus, D. W. Kwok, C. Hong, L. H. Chen, D. A. Carrera, M. Y. Zhang, N. O. Stevers, G. C. Maldonado, A. Yamamichi, P. Watchmaker, , H. Okada

The paper identifies tumor-specific alternative splicing events in glioma that could generate cell-surface antigens but finds significant spatiotemporal heterogeneity and lack of proteomic evidence.

bioRxiv · Oct 26, 2023Cancer Biology

Multi-antigen recognition circuits overcome challenges of specificity, heterogeneity, and durability in T cell therapy for glioblastoma

J. H. Choe, P. B. Watchmaker, M. S. Simic, R. D. Gilbert, A. W. Li, N. A. Krasnow, D. A. Carrera, W. Yu, K. M. Downey, A. Celli, J. Cho, J. D. Briones, R. Dannenfelser, L. Cardarelli, S. S. Sidhu, , W. A. Lim

This study develops multiantigen recognition circuits for CAR T cells to improve specificity, heterogeneity, and durability in glioblastoma treatment.

bioRxiv · Jan 7, 2021 · PreprintImmunology